United Arab Emirates

United Arab Emirates

United Arab Emirates

United Arab Emirates

Clinical Trial Application

n/a

Mandated Coverage

Yes

Standard Limits

USD 2,000,000

Tail Coverage

12 months

Data Required to Quote

• Clinical Trial Quote Request
• Protocol and Informed Consent Form
• Local CRO/Legal Representative details (Contact Person Name, Address, Telephone Number and E-Mail Address)

o Legal Representative details of the Sponsor in UAE to include authenticated documents proving ownership e.g. complete T/L, Share Certificate, Share Register, MOA, AOA, Annual Report, Ownership Chart etc. The document must clearly show the ownership % or holding shares and if there is any entity in the ownership pattern who holds >25% shareholding, futher ownership docs are required until the natural person with owning or controlling interests of >25% are identified.

o Completed KYC AML form

Oman

Oman

Clinical Trial Application

Oman Clinical Trial Quote Request

Clinical Trials Quote Request

Mandated Coverage

Yes, in most cases. Some ECs may accept the Master policy as evidence of coverage

Standard Limits

n/a

Tail Coverage

n/a

Data Required to Quote

• Clinical Trial Quote Request
• Protocol and Informed Consent Form in English
• Legal Representative details (Contact Person Name, Address, Telephone Number and E-Mail Address)
• Signed and completed Hold Harmless Agreement (to be provided separately by ABD Life Science team)
• Copy of the entity’s Commercial Register showing evidence that local company/entity is policy holder
- Oman requires a local company/entity to be the policy holder.
- Anti-Money Laundering regulations for Oman require that carriers provide evidence the policy holder is a registered company/entity in Oman – a copy of the entity’s Commercial Register

- No refund for policy cancellation